Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Piccini, Jonathan P. (BerichterstatterIn) , Hacke, Werner (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: Circulation
Year: 2013, Jahrgang: 127, Heft: 2, Pages: 224-32
ISSN:1524-4539
Online-Zugang:Verlag, Volltext: http://circ.ahajournals.org/content/127/2/224.full.pdf+html
Volltext
Verfasserangaben:Jonathan P. Piccini ... Werner Hacke ...

MARC

LEADER 00000caa a22000002c 4500
001 1485608937
003 DE-627
005 20220811134035.0
007 cr uuu---uuuuu
008 141015s2013 xx |||||o 00| ||eng c
024 7 |a 10.1161/CIRCULATIONAHA.112.107128  |2 doi 
035 |a (DE-627)1485608937 
035 |a (DE-576)415608937 
035 |a (DE-599)BSZ415608937 
035 |a (OCoLC)1340651223 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation  |b validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts  |c Jonathan P. Piccini ... Werner Hacke ... 
264 1 |c 2013 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
700 1 |a Piccini, Jonathan P.  |0 (DE-588)1059420627  |0 (DE-627)798397713  |0 (DE-576)415479223  |4 oth 
700 1 |a Hacke, Werner  |d 1948-  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 oth 
773 0 8 |i In  |t Circulation  |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 1950  |g 127(2013), 2, Seite 224-32  |h Online-Ressource  |w (DE-627)265784670  |w (DE-600)1466401-X  |w (DE-576)074891189  |x 1524-4539  |7 nnas  |a Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts 
773 1 8 |g volume:127  |g year:2013  |g number:2  |g pages:224-32  |g extent:9  |a Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts 
856 4 0 |u http://circ.ahajournals.org/content/127/2/224.full.pdf+html  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20141015 
993 |a Article 
994 |a 2013 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 910000  |d 911100  |e 910000PH12021699X  |e 911100PH12021699X  |k 0/910000/  |k 1/910000/911100/  |p 12 
999 |a KXP-PPN1485608937  |e 2817801091 
BIB |a Y 
SER |a newspaper 
JSO |a {"title":[{"subtitle":"validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts","title":"Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation","title_sort":"Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation"}],"id":{"doi":["10.1161/CIRCULATIONAHA.112.107128"],"eki":["1485608937"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"physDesc":[{"extent":"9 S."}],"person":[{"given":"Jonathan P.","family":"Piccini","display":"Piccini, Jonathan P.","role":"oth"},{"role":"oth","display":"Hacke, Werner","given":"Werner","family":"Hacke"}],"recId":"1485608937","type":{"bibl":"article-newspaper","media":"Online-Ressource"},"name":{"displayForm":["Jonathan P. Piccini ... Werner Hacke ..."]},"relHost":[{"part":{"volume":"127","year":"2013","extent":"9","text":"127(2013), 2, Seite 224-32","pages":"224-32","issue":"2"},"corporate":[{"role":"isb","display":"American Heart Association"}],"recId":"265784670","disp":"Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohortsCirculation","pubHistory":["1.1950 -"],"type":{"media":"Online-Ressource","bibl":"newspaper"},"language":["eng"],"id":{"eki":["265784670"],"zdb":["1466401-X"],"issn":["1524-4539"]},"title":[{"subtitle":"an official journal of the American Heart Association","title":"Circulation","title_sort":"Circulation"}],"origin":[{"dateIssuedKey":"1950","dateIssuedDisp":"1950-","publisher":"Lippincott, Williams & Wilkins ; Ovid","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]"}],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 10.10.2025"]}],"language":["eng"]} 
SRT |a RENALDYSFU2013